Delivery Order SPE2DB22D1103-SPE2DB24FTKN7
- Not listed
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Lantus Solostar 100 unit/mL 3mL insulin, a critical medication for the management of diabetes. The contract has a ceiling value of $2,672.10 and a completion date of February 15, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Lantus Solostar insulin medication. The contract has a ceiling value of $1,291.10 and a performance period through April 16, 2025. It is a firm-fixed-price contract, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,371.25 and is for the delivery of Lantus Solostar, a 100 unit/mL, 3mL insulin product, to support military healthcare programs. The contract has a firm fixed price pricing type and an ultimate completion date of May 16, 2024. This award is part of a larger Indefinite Delivery...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a prescription insulin medication. The contract has a ceiling value of $2,375.20 and a completion date of August 7, 2024. This award is a firm fixed price delivery order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $1,992.84 to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the supply of Lantus Solostar 100 unit/ml 3ml, a prescription insulin medication. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and Amerisourcebergen, valued up to $999,999,999.00 through December 2025. Under this IDC, Amerisourcebergen provides a comprehensive...
- This is a $8,455.38 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The order is for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a type of insulin medication. The contract has an ultimate completion date of August 19, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution services company. The contract is for the delivery of Lantus Solostar 100 unit/ml 3ml, a brand-name insulin product. The contract has a ceiling value of $1,187.60 and a period of performance through March 14, 2024. Amerisourcebergen Drug Corp is the...
- This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML insulin products. The contract has a ceiling value of $3,523.08 and an ultimate completion date of August 5, 2024. This award is not associated with a set-aside program. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the supply of Lantus SoloStar 100 unit/mL 3mL, a prescription insulin medication. The contract is a firm-fixed-price delivery order with a ceiling value of $1,724.09 and a completion date of February 17, 2023. The contract is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Lantus Solostar 100 unit/ml 3ml medication, with a ceiling value of $1,187.60 and a completion date of July 21, 2023. The contract is a firm fixed-price delivery order, with no set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a significant Indefinite Delivery Contract...
- SPE2DB22D1103Indefinite Delivery Contract
- SPE2DB22D1103-SPE2DB24FTKN7Delivery Order
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the Amerisourcebergen Corporation. The contract is for the delivery of 4,564,571,290 units of Lantus Solostar 100 unit/mL 3mL, a prescription insulin medication. The contract has a ceiling value of $1,420.88 and an ultimate completion date of May 13, 2024. This delivery order is issued against a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. The IDC enables the DLA to efficiently procure a comprehensive range of pharmaceutical products and medical supplies for military treatment programs and facilities globally. This particular delivery order was awarded on a full and open competition basis without any set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 5/10/24 |